Defies EO 14281: NYDFS Keeps NY Disparate Impact Rule
NYDFS is telling NY lenders that disparate impact still applies, directly contradicting Trump's EO 14281 and the CFPB's Regulation B rewrite.
NYDFS is telling NY lenders that disparate impact still applies, directly contradicting Trump's EO 14281 and the CFPB's Regulation B rewrite.
Jules v. Balazs locks federal courts onto post-arbitration jurisdiction for stayed FAA cases, closing the Badgerow gap businesses feared.
Three malicious node-ipc versions drain cloud keys, SSH creds, and CI/CD tokens via DNS; attacker hijacked an inactive npm maintainer's account.
Three AI coding agents fell at Pwn2Own Berlin for $65K in prizes, and the patch window for Cursor and Codex won't close for 90 days.
FDIC's transaction-level data shows the $49M-threshold depositors who drained SVB in six days, and they ran at Signature and First Republic too.
Japanese startup Reqrea left 1 million hotel passports in a public S3 bucket anyone could read. Its investigation has no published timeline.
Drift and Kelp DAO lost nearly $600M in April. Cybersecurity experts now say the speed of those attacks is consistent with AI assistance.
When FDA's CDER chief exits and other senior roles turn over at once, pharma has a genuine question: who's running the review process.
A federal judge stalled Anthropic's $1.5B copyright settlement Thursday, as authors earning $3,000 clash with lawyers seeking $320M in fees.
CFTC chairman Selig says the agency is chasing hundreds of insider trading tips on prediction markets, with AI surveillance tools now live.
Glass particles in 675 Sun Pharma cancer drug vials could trigger blood clots. The Indian plant making them has 10 years of FDA violations.
Senate committee cleared the CLARITY Act; banks are already lobbying to gut the stablecoin yield provisions before the floor vote.
The FTC's $53,088-per-violation deepfake rule starts May 19, and compliance attorneys already know which way platforms will lean on this.
Crypto's first federal rulebook passed committee 15-9, but needs 60 Senate floor votes and must clear a Trump family conflict-of-interest fight.
FDA's full clinical hold on ARD-101 sent Aardvark down 30%, and two analyst firms warn the cardiac signal may cap what safe doses can do.